首页> Diabetes: A Journal of the American Diabetes Association> GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K + channel

GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K + channel

导出原文传递

翻译打印收藏纠错

作者： Calabria,A.C. ^[1] ; Li,C. ^[2] ; Gallagher,P.R. ; Stanley,C.A. ; DeLeón,D.D.

作者单位： Division of Endocrinology, Children's Hospital of Philadelphia, Philadelphia, PA, United States ^[1] Clinical and Translational Research Center, Children's Hospital of Philadelphia, Philadelphia, PA ^[2]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes

2012年61卷10期

2585-2591页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K + channel

Diabetes

相似文献

Diabetes

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K + channel

Diabetes

相似文献

Diabetes

相关期刊

检索历史清除